Gut Dysbiosis and Immune System in Atherosclerotic Cardiovascular Disease (ACVD)
Atherosclerosis is a leading cause of cardiovascular disease and mortality worldwide. Alterations in the gut microbiota composition, known as gut dysbiosis, have been shown to contribute to atherosclerotic cardiovascular disease (ACVD) development through several pathways. Disruptions in gut homeost...
Main Authors: | Ji Youn Yoo, Sarah Sniffen, Kyle Craig McGill Percy, Veera Bramhachari Pallaval, Bojjibabu Chidipi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/10/1/108 |
Similar Items
-
制备光纤预制棒的ACVD工艺
by: 吴金东, et al.
Published: (2003-01-01) -
<i>Bacteroides fragilis</i> Supplementation Deteriorated Metabolic Dysfunction, Inflammation, and Aorta Atherosclerosis by Inducing Gut Microbiota Dysbiosis in Animal Model
by: Guoxiang Shi, et al.
Published: (2022-05-01) -
Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease
by: Salma Sultan, et al.
Published: (2021-09-01) -
Gut Microbiota Dysbiosis in Diabetic Retinopathy—Current Knowledge and Future Therapeutic Targets
by: Dragos Serban, et al.
Published: (2023-04-01) -
Gut Microbiota and Immune System Interactions
by: Ji Youn Yoo, et al.
Published: (2020-10-01)